Loading…
Lobbying Income
$700K
Filings
19
Unique Clients
1
Active Period
2009–2013
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. Senator Max Baucus' "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · first_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. Senator Max Baucus' "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. Senator Max Baucus' "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $40,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · fourth_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2009 · fourth_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · fourth_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $50,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · third_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. Senator Max Baucus' "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2009 · third_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. Senator Max Baucus' "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · third_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. Senator Max Baucus' "America's Healthy Future Act of 2009"
Client expense: — · Firm income: $40,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2009 · second_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH)
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics. H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Client expense: — · Firm income: $10,000
Matched citations: S.726
Source: Senate LDA